Use the tools below to filter the latest research and clinical trials.

337 Research & Clinical Trials match your filter criteria

  1. Page 1 of 34
  2.    < 1 2 3 4 5  ... > 
Research & Clinical Trials
Enrollment
A Phase 1a/1b Study of FPA008 in Combination with Nivolumab in Patients with Selected Advanced Cancers
Enrollment open
Lead Physician:
A Randomized, Placebo Controlled Phase 2b/3 Study of ABT-414 with Concurrent Chemoradiation and Adjuvant Temozolomide in Subjects with Newly Diagnosed Glioblastoma (GBM) with Epidermal Growth Factor Receptor (EGFR) Amplification
Enrollment open
Lead Physician: Sigmund Hsu, M.D.
Phase I Study of Methotrexate Infusion into the Fourth Ventricle in Children with Recurrent Malignant Fourth Ventricular Brain Tumors
Enrollment open
Lead Physician: David Sandberg, M.D.
Study of DCVax®-L to Treat Newly Diagnosed GBM Brain Cancer
Enrollment currently unavailable
Lead Physician: Jay-Jiguang Zhu, M.D.
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Enrollment open
Lead Physician: Jay-Jiguang Zhu, MD, PHD
Mobile Stroke Unit
Enrollment open
Lead Physician: James Grotta, M.D.
Phase III Randomized, 3-arm, Open label, Multicenter Study of LGX818 plus MEK162 and LGX818 Monotherapy Compared with Vemurafenib in Patients with Unresectable or Metastatic BRAF V600 Mutant Melanoma
Enrollment open
Lead Physician: Rabih Said, M.D.
Protocol: MEK162/LGX818 COLUMBUS
A Phase II Randomized, Multicenter study of Treatment Free Remission in Chronic Myeloid Leukemia in chronic Phase Patients who Achieve and Sustain MR4.5 After Switching to Nilotinib
Enrollment open
Lead Physician: Adan Rios, M.D.
Protocol: CAMN107A US37
A Randomized Multicenter Pivotal Study of CDX-011 in Patients with Metastatic, GPNMB over Expressing, Triple Negative Breast Cancer
Enrollment open
Lead Physician: Anneliese Gonzalez, M.D.
Protocol: CDX011-04 METRIC
Phase II/III, Multi Center, Open Label, Randomized Study of Weekly nab-Paclitaxel in Combination with Gemcitabine or Carboplatin, compared to Gemcitabine/Carboplatin, as First Line Treatment in Subjects with ER, PgR, and HER2 Negative, (Triple Negative) Metastatic Breast Cancer
Enrollment open
Lead Physician: Anneliese Gonzalez, M.D.
Protocol: ABI-007-MBC-001

337 Research & Clinical Trials match your filter criteria

  1. Page 1 of 34
  2.    < 1 2 3 4 5  ... >